# Effect of Glycerol Trierucate on Clinical Course of Adrenoleukodystrophy

> **NCT00004418** · PHASE2 · TERMINATED · sponsor: **Hugo W. Moser Research Institute at Kennedy Krieger, Inc.** · enrollment: 126 (actual)

## Conditions studied

- Adrenoleukodystrophy

## Interventions

- **DRUG:** glyceryl trierucate/glyceryl trioleate

## Key facts

- **NCT ID:** NCT00004418
- **Lead sponsor:** Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1998-04
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 126 (ACTUAL)
- **Why stopped:** No funding, move to expanded access
- **Last updated:** 2020-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004418, "Effect of Glycerol Trierucate on Clinical Course of Adrenoleukodystrophy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00004418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*